Director, HEOR Strategy - Oncology

Responsibilities

• HSL interacts/engages with cross-functional leaders for CLL disease area. Effectively communicates findings to internal leadership (Executive Leadership, Area VPs, GMs etc.) and external (e.g. HTAs/Payers, patient advocacy groups and KOLs etc.)
• Assumes full strategic V&E support of commercialization activities including the facilitation of obtaining and maintaining market access and growing/defending the market.
• Accountable for end-to-end delivery of V&E book of work under their remit, from strategy development to content pull through.
• Accountable for ensuring strong partnership with MHI, IMAP and all relevant V&E pillars to ensure a holistic and comprehensive voice to accelerate global patient access, in cross-functional meetings
• Partners with Heme-Oncology HEOR Strategy Team Lead to shape CLL oncology patient access policy environment, including successfully engaging and collaborating HTA/ payers, clinical practice guideline organizations and US oncology pathway stakeholders
• Partners with Heme-Oncology HEOR Strategy Team Lead to establish external alliances to drive Heme-Oncology payer/pathway centric fit-for-purpose evidence generation in support of pre- and post-launch assets
• Develops and maintains CLL oncology research partnerships with academic and community oncology centers and pathways to demonstrate the clinical, economic, humanistic and societal value of innovative AbbVie therapies
• Advanced degree required: MSc, MPH, or MBA with 10+ years of relevant experience; or PharmD/PhD with 7+ years in HEOR, market access, or a related research-focused field.
• Deep expertise in HEOR methods including health economic modeling, patient-reported outcomes, statistics, and real-world evidence, with strong experience in registry and observational study design, execution, analysis, and interpretation.
• Proven oncology HEOR and market access experience across pipeline, launch, in-line, and lifecycle management.
• Strong understanding of oncology health technology development and commercialization, including drugs and diagnostic devices.
• Highly effective influencer in matrixed environments, with the ability to align medical, clinical, access, affiliate, and commercial partners without direct authority.
• Track record of success in HTA/value assessment and engagement with key bodies such as NCCN, ESMO-MCBS, NICE, IQWiG, CADTH, MSAC, ICER, and similar organizations.
• Experience partnering with IDNs, GPOs, and collaborative groups to support external research initiatives.
• Thrives in fast-paced, high-accountability environments and can independently lead complex HEOR initiatives, including SLRs, ITCs, NMAs, PRO/PED studies, RWE, DCEs, economic models, and non-interventional studies.
• Strong strategic judgment with the ability to assess value, prioritize against business needs, and make decisions quickly and simply.
• Excellent interpersonal, oral, and written communication skills in English, with a track record of building strong internal and external partnerships.
• Strong project management skills, including contracting,

Benefits

Additional Information

The Oncology HEOR Strategy team, within the MHI Value & Evidence function, leads the creation and communication of transformative evidence to shape healthcare decision-making and make a remarkable impact for patients. Director, HEOR Strategy, CLL & Heme-Oncology (HEOR-S) - directs, develops, organizes, and implements the V&E strategy for Chronic Lymphocytic Leukemia (CLL) and disease adjacencies with concurrence of functional management to allow the development of each asset to proceed expeditiously and smoothly toward registration, PR&A and market launch in compliance with national and international governmental regulations for various asset programs, including CLL adjacencies. HSL reports to Senior Director, Heme-Oncology HEOR Strategy Team Lead and may have direct reports.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at Abbvie? Share your experience